| DBL PHARMACEUTICAL LIMITED |
| Registered number: |
13011110 |
| Balance Sheet |
| as at 30 November 2025 |
|
| Notes |
|
|
2025 |
|
|
2024 |
| £ |
£ |
| Current assets |
| Cash at bank and in hand |
|
|
144 |
|
|
- |
|
| Creditors: amounts falling due within one year |
2 |
|
20 |
|
|
100 |
|
| Net current assets |
|
|
|
164 |
|
|
100 |
|
| Net assets |
|
|
|
164 |
|
|
100 |
|
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
100 |
|
|
100 |
| Profit and loss account |
|
|
|
64 |
|
|
- |
|
| Shareholder's funds |
|
|
|
164 |
|
|
100 |
|
|
|
|
|
|
|
|
| The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The member has not required the company to obtain an audit in accordance with section 476 of the Act. |
| The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
|
| SILVIA-ELENA SPATARIU |
| Director |
| Approved by the board on 22 July 2026 |
|